What jumper's knee actually feels like

The most telling moment usually comes on landing — a sharp, localised ache at the very bottom of the kneecap that either stops you mid-session or lingers for hours afterwards. That spot, the inferior pole of the patella, is where the patellar tendon anchors to bone, and in jumper's knee it becomes the focal point of every load the leg absorbs.

The pain follows a consistent pattern. It builds during jumping, squatting, or walking down stairs, then quietens once you sit down or stop moving altogether. Rest, even briefly, tends to ease it. This load-dependence is one of its clearest signatures: if your knee hurts just as much when you are sitting still, something else may be contributing.

Many people also notice stiffness first thing in the morning after a heavy training day — a few minutes of hobbling before the tendon warms up. That morning-stiffness pattern, combined with a jumping sport background, is a useful pointer toward this diagnosis rather than other knee conditions.

One feature worth noting: jumper's knee does not cause the knee to swell. If your knee looks puffy, feels warm, or has fluid you can feel shifting beneath the skin, that points toward a different problem — a meniscal injury, an inflammatory joint condition, or something inside the joint itself — and warrants separate assessment.

Finally, do not rule out the diagnosis simply because both knees are affected. Published data suggest around 85% of athletes with this condition experience symptoms on both sides, often with one knee more troublesome than the other. Bilateral discomfort in a basketball or volleyball player is, if anything, more consistent with this diagnosis than a single painful knee.

How the diagnosis is confirmed

Specialist assessment follows a clear sequence: history first, hands-on examination, then targeted functional testing — imaging plays a supporting role, not a lead one.

The history establishes the load-dependent pain pattern, sport background, and symptom duration. Palpation of the inferior patellar pole then confirms whether tenderness is genuinely focal: a pinpoint ache precisely where the tendon meets the kneecap, rather than diffuse joint soreness, is a reliable indicator. When examination instead reveals joint-line tenderness, locking, or fluid in the joint, the clinician is redirected toward a different knee pathology — meniscal injury or an articular cause — rather than a tendinopathy pathway.

The key provocation test is the single-leg decline squat. Standing on the affected leg on a board angled at roughly 25 degrees and lowering slowly loads the patellar tendon under controlled conditions. Reproducing the patient's familiar inferior-pole pain on the symptomatic side — with little or no pain on the unaffected side — strongly supports the diagnosis. The 2025 UK Defence Rehabilitation consensus affirms that this clinical picture, not imaging, is the basis on which the diagnosis stands.

During or after examination, a short questionnaire called the VISA-P (Victorian Institute of Sport Assessment – Patella) scores pain, function, and sport participation out of 100. Symptomatic athletes typically score between 57 and 68; asymptomatic controls score around 93. That starting number matters: it becomes the reference point against which every subsequent intervention — physiotherapy, shockwave, injection — is measured.

Ultrasound and MRI can reveal structural changes such as tendon thickening or disrupted collagen organisation, but a 2024 systematic review and meta-analysis found that imaging changes do not reliably correspond to VISA-P improvements. A scan showing tendon abnormality without matching clinical symptoms is not, on its own, a treatment target.

What physiotherapy involves and what to expect

Progressive loading of the patellar tendon is the treatment — not rest, ice, or generic stretching. The tendon adapts and remodels in response to carefully applied stress, and removing that stress entirely delays recovery. A physiotherapist structures this as a tiered programme, beginning with exercises that place modest demand on the tendon and advancing only as pain allows.

In practical terms, early sessions typically centre on double-leg exercises at a shallow knee-bend angle — around 60 degrees — and step-ups. As tolerance improves, the programme moves toward the Spanish squat, loaded lunges, and eventually the single-leg decline squat and plyometric tasks that represent full sport-level demand. This progression is guided by the athlete's pain response at each stage, not by a fixed calendar.

Heavy slow resistance training and eccentric loading programmes are the two most established methods within this framework, both producing meaningful improvements in VISA-P scores. For athletes who find high tendon loads too painful in the early weeks, blood flow restriction training (BFR) — using a light-load exercise with a cuff to partially restrict venous return — produces comparable clinical improvements at both 12 and 52 weeks and offers a route forward when conventional loading is not yet tolerable.

On timeline: most athletes do recover, but the process is measured in months and, in persistent cases, years. Five-year follow-up data show that 76% of athletes feel recovered and VISA-P scores rise from a median of approximately 57 to 82 — a meaningful gain, but a slow one. Around 9% cease sport participation entirely. Setting that expectation early is important; progress that feels slow is not necessarily stalling.

Signs that physiotherapy alone is not working

The benchmark is structured, supervised exercise — three to six months of it, consistently applied and progressed — not a few weeks of self-directed stretching or intermittent gym sessions. When that period passes without meaningful change, two clinical indicators point toward escalation.

The primary signal is a VISA-P score that remains below approximately 70 despite genuine programme adherence. The second is persistent inability to train or compete at a meaningful level — not just discomfort during loading, but a real ceiling on sport participation that the athlete cannot push through. Symptom duration reinforces both: when pain and functional limitation extend well past six months without progressive VISA-P improvement, the case for adjunctive treatment strengthens regardless of how conscientiously the rehabilitation has been followed.

These thresholds — the 70-point VISA-P floor, the three-to-six-month window — are established working benchmarks drawn from expert consensus rather than from a single definitive trial, which is also why a clinician will weigh them alongside your sport demands, training goals, and the trajectory of your scores, rather than applying a fixed rule to everyone.

Escalation does not signal that physiotherapy has failed. The standard pathway anticipates from the outset that a proportion of athletes will need additional support; moving to the next stage is planned, not reactive. For those who do meet escalation criteria, the two adjuncts with the strongest current evidence are focused shockwave therapy and ultrasound-guided PRP injection — what they involve, and what the evidence shows, is covered in the sections that follow.

Escalation options: ESWT and PRP

Both adjuncts work alongside continued loading — neither replaces the exercise programme that has been running in the background.

Focused shockwave therapy (ESWT)

ESWT delivers targeted acoustic energy directly to the tendon through the skin, typically in four weekly sessions. A 2025 prospective cohort study found that this protocol produced significant reductions in pain scores (measured by numerical rating scale) and meaningful improvements on the VISA-P, alongside measurable changes in tendon structure — reduced tendon diameter and improved collagen organisation on ultrasound — at three-month follow-up. It is non-invasive and is generally well tolerated, though the sessions themselves can be uncomfortable at the tendon site.

Ultrasound-guided PRP injection

PRP (platelet-rich plasma) involves drawing a small volume of the patient's own blood, concentrating the growth-factor-rich platelet fraction, and injecting it directly into the tendon under real-time ultrasound guidance. The standard protocol is three injections, each two weeks apart. Prospective series have reported stable clinical outcomes at up to four years in athletes with recalcitrant tendinopathy, with MRI evidence of a return to near-normal tendon architecture in some cases. Long-term comparative safety data remain limited, which is why the 2025 UK Defence Rehabilitation consensus recommends offering PRP on an individualised basis rather than routinely.

Choosing between them

No head-to-head RCT has established a definitive sequencing or superiority between ESWT and PRP in patellar tendinopathy. In practice, the choice is guided by symptom duration, prior treatment response, and individual clinical factors — decisions best made through consultant assessment rather than by a fixed protocol.

Red flags and when surgery becomes relevant

Three clinical signs demand same-day attention, regardless of where someone is in their rehabilitation programme.

A palpable gap or step in the tendon, a sudden loss of the ability to straighten the knee against gravity, or a patella that sits abnormally high (patella alta) each point toward complete patellar tendon rupture rather than ongoing tendinopathy. Unlike tendinopathy, rupture is a surgical priority: the interval between injury and repair is the single most important factor governing outcome. Repair is typically achieved through transosseous tunnels or suture anchors, restoring continuity of the extensor mechanism; return to sport after uncomplicated repair is generally anticipated around six months post-operatively, progressing through criteria-based functional milestones rather than a fixed date.

For the smaller group of patients with degenerative — non-ruptured — tendinopathy that has genuinely exhausted structured exercise rehabilitation, shockwave therapy, and PRP, surgery remains available as a final resort. Evidence supports this step only after the full conservative and injection-based pathway has been completed and documented.

There is also a practical reason not to leave a stalled conservative pathway unaddressed: long-standing, uncontrolled tendinopathy does increase the susceptibility of a chronically altered tendon to low-energy rupture. Most patients working through the rehabilitation stages described in earlier sections will never reach this point — but recognising these warning signs early, and escalating promptly when they appear, is what keeps that risk off the table.

1. [1] UK Defence Rehabilitation consensus agreement for the conservative management of Achilles and patellar tendinopathy. (2025). https://doi.org/10.1136/military-2024-002893 https://doi.org/10.1136/military-2024-002893
2. [2] Patellar Tendon Load Progression during Rehabilitation Exercises: Implications for the Treatment of Patellar Tendon Injuries. (2023). https://doi.org/10.1249/MSS.0000000000003323 https://doi.org/10.1249/MSS.0000000000003323
3. [3] Reliability and Validity of the VISA-P Questionnaire for Patellar Tendinopathy in Adolescent Elite Volleyball Athletes. (2013). https://doi.org/10.5535/arm.2013.37.5.698 https://doi.org/10.5535/arm.2013.37.5.698
4. [4] Long-term Prognosis of Athletes With Patellar Tendinopathy Receiving Physical Therapy: Patient-Reported Outcomes at 5-Year Follow-up. (2025). https://doi.org/10.1177/03635465251336466 https://doi.org/10.1177/03635465251336466
5. [5] Effect of Low-Load Blood-Flow Restricted Training Versus Heavy Slow Resistance Training in Unilateral Patellar Tendinopathy: A Randomized Clinical Trial. (2025). https://doi.org/10.1111/sms.70186 https://doi.org/10.1111/sms.70186
6. [6] Acute Patellar Tendon Ruptures: An Update on Management. (2024). https://doi.org/10.5435/JAAOSGlobal-D-24-00060 https://doi.org/10.5435/JAAOSGlobal-D-24-00060
7. [7] Rehabilitation exercise program after surgical treatment of patellar tendon rupture: A case report. (2024). https://doi.org/10.1016/j.ptsp.2024.01.001 https://doi.org/10.1016/j.ptsp.2024.01.001
8. [8] Self-reported bio-psycho-social factors partially distinguish patellar tendinopathy from other knee problems. (2023). https://doi.org/10.1016/j.ptsp.2023.02.009 https://doi.org/10.1016/j.ptsp.2023.02.009
9. [9] Endogenous pain modulation is not different in basketball or volleyball athletes with patellar tendinopathy compared to asymptomatic athletic controls. (2025). https://doi.org/10.1016/j.msksp.2025.103280 https://doi.org/10.1016/j.msksp.2025.103280
10. [10] Patellar tendinitis (Jumper's Knee). https://en.wikipedia.org/?curid=2533397 https://en.wikipedia.org/?curid=2533397
11. [11] ESWT is able to change macromorphological and micromorphological parameters in patellar tendinopathy: a prospective cohort study. (2025). https://doi.org/10.1097/JS9.0000000000002351 https://doi.org/10.1097/JS9.0000000000002351
12. [12] Congruency of Ultrasound Measure Changes Against Patient-Reported Outcome Measures in Patellar Tendinopathy: A Systematic Review and Meta-Analysis. (2024). https://doi.org/10.7759/cureus.74200 https://doi.org/10.7759/cureus.74200